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PURPOSE. Progressive retinal ganglion cell (RGC) loss is the pathological hallmark of autosomal
dominant optic atrophy (DOA) caused by pathogenic OPA1 mutations. The aim of this study
was to conduct an in-depth psychophysical study of the visual losses in DOA and to infer any
selective vulnerability of visual pathways subserved by different RGC subtypes.
METHODS. We recruited 25 patients carrying pathogenic OPA1 mutations and age-matched
healthy individuals. Spatial contrast sensitivity functions (SCSFs) and chromatic contrast
sensitivity were quantified, the latter using the Cambridge Colour Test. In 11 patients, long (L)
and short (S) wavelength–sensitive cone temporal acuities were measured as a function of
target illuminance, and L-cone temporal contrast sensitivity (TCSF) as a function of temporal
frequency.
RESULTS. Spatial contrast sensitivity functions were abnormal, with the loss of sensitivity
increasing with spatial frequency. Further, the highest L-cone temporal acuity fell on average
by 10 Hz and the TCSFs by 0.66 log10 unit. Chromatic thresholds along the protan, deutan,
and tritan axes were 8, 9, and 14 times higher than normal, respectively, with losses
increasing with age and S-cone temporal acuity showing the most significant age-related
decline.
CONCLUSIONS. Losses of midget parvocellular, parasol magnocellular, and bistratified
koniocellular RGCs could account for the losses of high spatial frequency sensitivity and
protan and deutan sensitivities, high temporal frequency sensitivity, and S-cone temporal and
tritan sensitivities, respectively. The S-cone–related losses showed a significant deterioration
with increasing patient age and could therefore prove useful biomarkers of disease
progression in DOA.
Keywords: dominant optic atrophy (DOA), OPA1, critical flicker fusion, magnocellular,
koniocellular, parvocellular
Autosomal dominant optic atrophy (DOA; Online MendelianInheritance in Man [OMIM] 165500) is characterized by
slowly deteriorating visual acuity, impaired color vision, and
central field defects.1–3 The majority of patients with DOA carry
a heterozygous mutation in the OPA1 gene (OMIM 605290),
which encodes for an inner mitochondrial membrane protein
involved in myriad cellular functions, including mitochondrial
biogenesis, the maintenance of the delicate balance between
mitochondrial fusion and fission forces, and the regulation of
apoptosis.4–6 Despite the ubiquitous cellular nature of mito-
chondria, the neuropathology is frequently limited to retinal
ganglion cells (RGCs) within the inner retina, and the
mechanisms that underlie this selective vulnerability have still
not been fully defined.1–3 Affected individuals usually become
symptomatic in childhood, and several optical coherence
tomography studies have confirmed the early loss of RGCs.7–11
However, there is a marked inter- and intrafamilial variation in
the severity and rate of progression of the disease, and the exact
pattern and chronology of RGC loss are not fully under-
stood.2,10,11
Visual information from the photoreceptors is transmitted
by the bipolar cells to RGCs that in turn project their axons to
the lateral geniculate nucleus and the superior colliculus. Three
major visual pathways, namely, the parvo-, magno-, and
koniocellular pathways, have been distinguished based on their
RGC population and the nature of the transmitted visual
information. The predominant RGC population is the midget
cells that form the parvocellular pathway, which is thought to
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transmit achromatic visual information of high spatial, but low
temporal resolution, and also red–green chromatic information
produced by opponent long (L) and middle (M) wavelength–
sensitive cone signals. Parasol cells constitute a smaller
proportion of RGCs, and their L- and M-cone inputs form the
magnocellular pathway, which transmits achromatic visual
information of high temporal but low spatial resolution.
Parallel processing in the retina and early visual pathway has
been the subject of several excellent reviews.12–19 The
relatively sparse small bistratified RGCs that form part of the
koniocellular visual pathway are excited by short (S)-wave-
length cones and inhibited by L- and M-cones, and they
transmit a blue–yellow chromatic signal. The S-cones and their
pathways have been the subject of several recent reviews.20–23
Unlike conventional clinical visual tests that distinguish
relatively poorly between different visual pathways, advanced
psychophysical methods can be designed that selectively test
the performance of one individual pathway.24 However, it
should be recognized that although concrete links are often
made between these physiological pathways and psychophys-
ical performance on various tasks, they are inevitably
hypothetical and to some extent tenuous. In the context of
DOA, psychophysical studies have focused mainly on color
vision and have shown various deficits that tended to be most
severe for discrimination along the tritan axis.1,25–29 There are
two reports detailing deficits in the parvocellular and
magnocellular pathways in DOA, with one showing abnormal
achromatic contrast sensitivities and the other abnormal
peripheral motion detection thresholds.1,28 Although both
parvocellular and magnocellular pathways seem to be involved
in visually affected patients, the severity and progression of
deficits with increasing age remain unclear.
In this study, we used temporal, spatial, and chromatic
psychophysical tests to assess the magno-, parvo-, and
koniocellular pathways in patients with DOA caused by
pathogenic OPA1 mutations. The psychophysical temporal
test protocols have previously been used in our laboratory to
study various retinal pathologies.30–33 Our aim in this work was
to characterize the visual losses, and to infer any selective
losses in visual pathways subserved by different RGC types.
The deficits observed for these functional visual parameters
were also related to structural measures, namely, the thick-
nesses of the macular RGC and the peripapillary retinal nerve
fiber layers (RNFL), and to the patient’s age.
METHODS
Participants
We included 25 patients with DOA from 15 independent
families carrying 13 different pathogenic sequence variants in
the OPA1 gene. The genetic testing was performed in the Leeds
Genetics Laboratory (St. James’s University Hospital, Leeds,
UK) and as part of two previously reported studies.4,34 All
patients underwent achromatic spatial contrast sensitivity and
color discrimination tests and the following ophthalmologic
investigations: best-corrected visual acuity (BCVA) using the
Early Treatment Diabetic Retinopathy Study (ETDRS) charts,35
static computer-automated white-on-white threshold perimetry
(Swedish Interactive Testing Algorithm fast 30-2 Humphrey
visual field [model 740; Humphrey Instruments, Dublin, CA,
USA]), and optical coherence tomography (OCT) imaging of
the macula and optic nerve head (see details below). The
demographics, genotypes, and clinical characteristics of the
DOA patients are given in Table 1. Eleven of the 25 DOA
patients (P1–11) also performed an extended psychophysical
test protocol that included L- and S-cone temporal vision tests.
The genotypes and clinical data for all patients are given in
Table 2. Normative spatial contrast sensitivity and chromatic
sensitivity data were obtained from 15 individuals (aged 17–78
years old at the time of testing) with normal or corrected-to-
normal visual acuities, and normal color vision as assessed by
standard color vision tests (the Farnsworth-Munsell 100 hue
test, The Hardy-Rand-Rittler [HRR] pseudoisochromatic test,
and the Ishihara color vision test). These measurements were
made as part of this study. Normative temporal acuity was also
measured in 15 individuals (aged 17–67 years old at the time of
testing). Three of them were studied as part of this study and
12 are taken from a previous study that used the same
conditions as those used here.31,33 Similarly, normative
temporal contrast sensitivity data (n ¼ 8) were taken from a
previous study.31,33
L- and S-Cone Critical Flicker Fusion and L-Cone
Modulation Sensitivity Measurements
L- and S-cone temporal acuities (critical flicker fusion, CFF) and
L-cone temporal modulation sensitivity were measured using a
Maxwellian-view optical system described in detail else-
where.33,36 Two types of stimuli were used for the CFF
TABLE 1. Demographics, Genotypes, and Clinical Data of the DOA Patients
Genotype OPA1 Mutation Patients, n Sex, f/m
Age, y, Range
(Median)
BCVA, logMAR,
Mean 6 SD†
Visual Field Defect MD,
dB Mean 6 SD†
1 c.2708_2711del 5* 3/2 19–47 (25) 0.8 6 0.3 7.8 6 3.5
2 c.1296delCAT 4 2/2 23–58 (44) 0.9 6 0.3 5.7 6 2.5
3 c.3G>A, c.113_130del 2 2/0 15–50 0.3 6 0.2 3.4 6 2.1
4 c.876-878del 2 1/1 39–47 0.5 6 0.1 5.3 6 1.2
5 c.2063delA 1 1/0 54 1.1 6 0 4.0 6 0.9
6 c.2102_2103del 1 1/0 27 0.7 6 0.1 5.0 6 0.6
7 IVS27þ6T>C 2 1/1 29–52 0.8 6 0.1 5.6 6 1.0
8 IVS9þ3A>T 2 2/0 27–60 1.1 6 0.4 5.8 6 2.9
9 c.2818þ5G>A 1 0/1 47 0.5 6 0.1 6.2 6 0.4
10 c.733A>T 2 1/1 34–64 1.5 6 0.1 14.8 6 11.4
11 c.112C>A 1 1/0 39 1.6 6 0 24.8 6 0.3
12 c.1187T>G 1 1/0 43 0.9 6 0.1 5.8 6 0.3
13 c.1213-2A>G 1 1/0 13 0.6 6 0.1 9.7 6 2.5
All 25 17/8 13–65 (40) 0.8 6 0.4 7.4 6 5.8
f, female; m, male; MD, mean deviation.
* Three independent families.
† Data of both eyes included.
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measurements: The L-cone stimulus was a flickering, mono-
chromatic, circular target with a diameter subtending 48 of
visual angle and a wavelength of 650 nm. The target was
presented in the center of a 98 diameter circular background
field of 481 nm. The S-cone stimulus was also a flickering
circular target of 48 diameter but of 440 nm in wavelength
presented in the center of a 98 diameter background field of
620 nm in wavelength. For L-cone modulation sensitivity
measurements, the time-averaged mean radiances of the 481-
nm background and 650-nm target were fixed at 8.3 and 10.6
log quanta s1deg2, respectively. The observers varied the
modulation of the sinusoidally flickering 650-nm target to find
the modulation at each target frequency at which the flicker
was just visible. In the CFF measurements, observers varied the
frequency of the 650- or 440-nm target, which was sinusoidally
flickering with a contrast of 92%, to find the frequency at
which the flicker was just visible for a range of target radiances.
Before each run, the observers light adapted to the background
and target for 2 minutes. The observers viewed the stimuli
monocularly with the eye they preferred (as indicated by the
asterisk in Table 2) and interacted with the computer by means
of an eight-button keypad as previously described.33 Each
experiment was repeated two or three times on the same day.
Details of these measurement techniques have been given
elsewhere.33
Achromatic Spatial Contrast Sensitivity Function
(CSF)
The achromatic spatial contrast sensitivity function, the SCSF,
was measured as a function of spatial frequency. The target
stimuli were generated on a gamma-corrected Sony Trinitron
monitor (model GDM F520; Sony Electronics, Inc., Park Ridge,
NJ, USA) with 85-Hz frame rate and a resolution of 160031200
pixels connected to a DataPixx video processor (VPixx
Technologies, Inc., Saint-Bruno, QC, Canada). The full screen
subtended a visual angle of 398 3 298 at the test distance of
0.57 m. The experiments were performed at a constant mean
luminance of 44.57 cd.m2 as measured using a ColorCal
calibration device (Cambridge Research Systems Ltd., Ro-
chester, UK). The stimuli were circular centrally presented,
horizontally oriented Gabor patterns with spatial standard
deviations of 68 and spatial frequencies ranging from 0.25 to 16
cycles per degree (cyc/deg). The target duration was 500 ms,
preceded and followed by 100-ms cosine-windowed onsets and
offsets. The order of presentation was from low to high spatial
frequencies. Thresholds were measured using a Yes/No
staircase procedure. By means of a two-button keypad,
observers indicated whether they could detect the Gabor
pattern.
Stimulus contrast (Michelson contrast) was defined as (Lmax
 Lmin)/(Lmax þ Lmin), where Lmax and Lmin are the maximum
and minimum luminances in the Gabor pattern, respectively.
Contrast was adjusted following a one-up-one-down staircase
procedure with a variable step size. For the first five reversals
(changes in the direction of the staircase) the step size was 0.3
log units, after which the step size was reduced to 0.2 log units
for two more reversals and then finally to 0.1 log unit for the
last four reversals. A single run required a total of nine
reversals, with the contrast ‘‘threshold’’ taken as the average of
the last six reversals. Contrast sensitivity is the reciprocal of the
contrast threshold. The spatial contrast sensitivity measure-
ments lasted approximately 20 minutes for each observer. The
TABLE 2. Characteristics of the DOA Patients
Patient Age, y; Sex OPA1Mutation
BCVA, logMAR* Visual Field Defect MD, dB*
RE LE RE LE
P1 13 f c.1213-2A>G 0.5* 0.6 11.5* 7.9
P2 24 m c.2708-2711del 0.5 0.4* 3.7 5.9*
P3 27 f IVS9þ3A>T 0.8 0.7* 2.6 4.3*
P4 29 m IVS27þ6T>C 0.9 0.8* 6.0 6.3*
P5 39 f c.876-878del 0.5* 0.4 3.6* 3.7
P6 47 f c.2708-2711del 1.0* 1.1 6.8* 9.8
P7 47 m c.876-878del 0.5 0.5* 6.9 7.1*
P8 47 m c.2818þ5G>A 0.5* 0.4 6.5* 6.0
P9 52 f IVS27þ6T>C 0.7 0.7* 4.2 5.7*
P10 54 f c.2063delA 1.1* 1.1 3.4* 4.6
P11 25 f c.2708-2711del 0.7* 1.2 7.9* 10.0
P12 34 m c.1296delCAT 0.4 0.3 2.4 3.8
P13 46 f c.2708-2711del 0.7 0.6 12.4 15.6
P14 28 f c.2102_2103del 0.7 0.6 5.4 4.5
P15 59 f c.1296delCAT 1.4 1.2 10.3 6.6
P16 24 f c.1296delCAT 0.7 0.6 5.9 5.6
P17 56 m c.1296delCAT 1.0 1.0 3.8 7.2
P18 20 m c.2708-2711del 0.8 0.8 12.9 12.5
P19† 40 f c.112C>A 1.6 1.6 31.1 29.1
P20† 65 f c.733A>T 1.9 1.51 23.0 26.3
P21 15 f c.3G>A,c.113_130del 0.2 0.1 1.2 2.0
P22 51 f c.3G>A,c.113_130del 0.6 0.5 5.0 5.3
P23 44 f c.1187T>G 0.8 0.9 6.0 5.9
P24† 35 m c.733A>T 1.4 1.4 19.0 7.5
P25 61 f IVS9þ3A>T 1.3 1.3 8.8 7.6
Eleven patients (P1–P11) underwent an extended psychophysics study protocol. All patients participated in the spatial and color measurements.
LE, left eye; MD, mean deviation; RE, right eye.
* Indicates BCVA and MD of the eye used for the monocular tests.
† Patients 19, 20, and 24 could not see any color in the CCT test.
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stimuli were viewed binocularly with appropriate corrections
if needed.
Modeling Contrast Sensitivity Functions
In order to characterize the temporal and spatial contrast
sensitivities, and how they differ between patients and control
subjects, we fitted a cubic function in log–log coordinates,
log10(S) ¼ a log10(f) þ b log10(f) þ c log10(f) þ d; where S is
temporal or spatial contrast sensitivity, f is the frequency (Hz
for temporal, and cyc/deg for spatial), and a, b, c, and d are
constants. The cubic function here has no theoretical basis, but
was chosen for its simplicity and because it provided a good fit
to both the temporal and the spatial contrast threshold data for
both the normal controls and the patients and therefore could
be used to parameterize the contrast sensitivity functions.
Chromatic Discrimination
Chromatic discrimination was tested using the Trivector test
procedure implemented as part of the Cambridge Colour Test
(CCT) (v1.5; Cambridge Research Systems Ltd.). The test was
performed using a gamma-corrected Sony FD Trinitron color
monitor (model GDM-F500R) connected to a VSG 2/5 visual
stimulus generator (Cambridge Research Systems Ltd.) with
800- by 600-pixel resolution. The cathode ray tube (CRT)
phosphors were measured, in CIE 1976 u0v0 chromaticity
coordinates with a ColorCal photometer (Cambridge Research
Systems Ltd.): red phosphor (R) u0 ¼ 0.416; v0 ¼ 0.522 (x ¼
0.610, y¼ 0.340); green phosphor (G) u0 ¼ 0.117; v0 ¼ 0.559 (x
¼0.280, y¼0.595); blue phosphor (B) u0 ¼0.159; v0¼0.177 (x
¼ 0.142, y ¼ 0.070). The visual stimuli consisted of letter C
targets presented on a background of neutral chromaticity (CIE
1976 coordinates u0 ¼ 0.1977, v0 ¼ 0.4689). The background
and the target consisted of small circles of variable size and
luminance (10 equal steps between 8.0 and 18.0 cd.m2).
The test conditions were modified to be appropriate for
observers with markedly reduced visual acuity. The viewing
distance was set so that the gap in the letter C opening
subtended 58 instead of 18 of visual angle. (For our system, this
corresponded to a viewing distance of 62.6 cm.) Thresholds
were measured along the three dichromat confusion lines,
protan, deutan, and tritan, but the highest target saturation was
increased to 1600 3 104 u0v0 units and the number of steps
from 6 to 10 in order to maintain the standard unit difference
between the steps. The time allowed for the subject to respond
was increased from the standard 8 to 20 seconds. The test was
then run using a standard one-up, one-down psychophysical
staircase procedure with six reversals.37 The observers were
instructed to respond to the gap position (four-alternative
forced choice) by means of a four-button keypad. The test was
performed binocularly with appropriate near corrections if
needed.
The CCT depends on commercial software and hardware
that uses a derivation of the 28 CIE standard observer data to
generate the test stimuli and interpret the results. Although the
28 observer is plausible for normal control measurements,
since normal observers used central vision and stimuli with
gaps of 18, it is not ideal for DOA patients who use larger
targets and who can suffer from central scotomas. Unfortu-
nately, the CCT cannot be modified for a larger field. Failures to
isolate an aberrant cone response, however, should decrease
thresholds, not increase them—as we find.
Structural Studies
The Spectralis platform (Heidelberg Engineering Ltd., Heidel-
berg, Germany) was used for macular SD-OCT imaging.
FIGURE 1. L-cone critical flicker fusion. (A, B) L-cone critical flicker
frequencies (CFF) measured on a 481-nm background of 8.3 log10
quanta s1deg2 and plotted as a function of the mean log10 radiance of
a 650-nm flickering target. (A) Data are plotted as mean 6 1 SEM for
each DOA patient indicated with individually colored symbols and as
gray symbols for the mean normal observer. (B) The pink symbols
denote the mean 6 1 SEM across all DOA patients (except for the
lowest two radiances that could be detected only by six and nine
patients, respectively), and gray symbols again denote the mean of 15
normal observers (61 SEM across observers). The Ferry-Porter slopes
of mean CFF for DOA and normal observers are indicated by the blue
lines. (C) The L-cone CFF frequencies at 8.5 log10 quanta s1deg2
plotted as a function of observer age for normal (gray symbols) and
DOA patients (pink symbols). The solid gray and pink lines show the
best fits for linear regression for normal and DOA patients,
respectively—the dashed lines, the 95% confidence interval for the
best-fitting linear regressions.
Visual Losses Related to Retinal Ganglion Cell Losses in DOA IOVS j January 2017 j Vol. 58 j No. 1 j 505
Automated segmentation and thickness analyses were per-
formed for perifoveal volumetric retinal B-scans using the
Heidelberg Engineering segmentation tool, included in the
Spectralis Glaucoma Module software (version 6.0). The
combined thickness of the ganglion cell layer (GCL) and inner
plexiform layer (IPL) was recorded as mean of the four sectors
of the inner ring (between 1 and 3 mm in diameter) of the nine
macular ETDRS subfields as described elsewhere.38 Normative
data for the GCL-IPL thickness was generated from SD-OCT
images of 48 healthy eyes of 48 subjects.38 Peripapillary RNFL
thickness measurements were performed using the Cirrus HD-
OCT 4000 (Carl Zeiss Meditec, Inc., Dublin, CA, USA) platform.
The mean RNFL thickness was recorded.
Statistical Analyses
Mann-Whitney U independent samples test was used for
comparison of distribution of continuous variables in DOA and
normal observers, and in males and females, as indicated.
Pearson product–moment correlation coefficient was used for
the analysis of statistical dependence between various vari-
ables indicated in the Results section. Temporal functions were
analyzed in DOA P1 to P11 within the data for the eyes used for
the monocular temporal tests. All other variables were studied
in the entire DOA study group. Binocular test data (CSF and
CCT) were compared with the monocular data of the eye with
the better BCVA. Monocular tests were analyzed for each eye
separately.
The study was approved by local ethics committees at
Moorfields Eye Hospital and at University College London and
conformed to the standards set by the Declaration of Helsinki.
All subjects or their parents signed informed consent forms.
RESULTS
L-Cone Temporal Functions
Figure 1A shows L-cone CFF (temporal acuity) data for the 11
DOA (P1–P11) and 15 normal observers plotted as a function
of log10 target radiance. The mean data for 15 normal observers
are shown by gray symbols, and the individual data for each
DOA patient are shown by the colored symbols, as means 6 1
SEM. In the normal observers, the mean lowest target radiance
at which flicker was seen was 6.6 log10 quanta s
1deg2, after
which the CFF rises until it approaches a plateau near 40 Hz.
Most DOA patients are unable to see the flicker at such a low
radiance and require, on average, a radiance of 7.4 log10 quanta
s1deg2 before flicker can be observed. For them the
asymptotic upper bound on flicker rate is highly variable,
ranging from 24 to 35 Hz.
The mean data (61 SEM across observers) for normal and
DOA observers are shown in Figure 1B with gray and pink
symbols, respectively. Over two and half log10 units the
normal CFF increases as an approximately linear function of
log10 radiance with a slope of 9.2 Hz per decade as shown by
the blue line fitted to the mean normal data. This behavior is
known as obedience to the Ferry-Porter law.39,40 For the DOA
patients (pink triangles in Fig. 1B), the Ferry-Porter slope, also
shown by a blue line, is 7.3 Hz per decade. Slope fits were
also made to the individual DOA data over the range of CFFs
consistent with the Ferry-Porter law and are tabulated in
Table 3.
Figure 1C shows the L-cone CFF obtained at 8.5 log10
quanta s1deg2 plotted as a function of observer age for
normal (gray symbols) and DOA observers (pink symbols). The
solid gray and pink lines show the best fits for linear regression
for normal and DOA observers, respectively, and the dashed
lines indicate the 695% confidence interval for the fits. Over
the range of ages observed, L-cone CFF did not show any
significant age-related variation either for the DOA or for the
normal observers (Pearson’s r ¼0.474, P ¼ 0.140 for DOA
observers, and r¼0.018, P¼0.950 for normal observers). For
the DOA observers (see Table 3), the L-cone plateau showed
weakly significant age-related decreases (Pearson’s r¼0.596,
P ¼ 0.053), and the Ferry-Porter slope weakly significant
increases (r ¼ 0.613, P ¼ 0.045 for the Ferry-Porter slope).
Table 3 summarizes the CFF data and the Ferry-Porter fits:
Column 2 shows the lowest detected target radiance and the
mean value (6SEM) for 11 DOA patients, and the mean value
(6SEM) for the normal observers. Columns 3 and 4 show the
best-fitting Ferry-Porter slope together with the R2 value for the
fit; columns 5 and 6 show the CFF obtained at 8.5 log10 quanta
s1deg2 interpolated from the Ferry-Porter slope together with
the plateau frequency.33 Dominant optic atrophy patients first
detected flicker at the mean radiance eight times (0.91 log
unit) more intense than that for normal observers. In all DOA
patients, CFF followed the Ferry-Porter law over a radiance
range similar to that of normal observers, but in all patients the
TABLE 3. L-Cone Critical Flicker Fusion Variables
Observer
L-Cone
Lowest Radiance,
log10 quanta s1deg2
Ferry-Porter Slope,
Hz per Decade R2
CFF, Hz, at 8.5 log10
quanta s1deg2 Radiance
Plateau CFF,
Hz, at 10.3–10.6 log10
quanta s1deg2
P1 7.47 5.81 0.95 22.81 34.84
P2 7.16 7.53 0.98 24.96 34.39
P3 7.49 6.10 0.94 18.29 26.34
P4 7.54 6.11 0.97 16.14 29.17
P5 7.75 7.81 0.99 20.55 32.22
P6 8.04 7.14 0.98 20.11 29.00
P7 7.74 6.77 0.92 16.73 25.82
P8 6.89 6.78 0.99 19.58 30.11
P9 7.48 6.83 0.97 15.31 27.34
P10 7.78 8.30 0.90 21.53 28.89
P11 7.77 5.27 0.96 23.09 30.61
DOA mean 6 SE 7.56 6 0.10 7.32 6 0.27 0.96 6 0.01 19.01 6 0.93 29.88 6 0.91
Normal mean 6 SE 6.65 6 0.06 9.16 6 0.35 0.998 27.90 6 0.91 40.18 6 0.88
Mann-Whitney U test, P <0.001 <0.001 <0.001 <0.001
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Ferry-Porter slope was shallower. This and the overall loss of
sensitivity gives a mean reduction in CFF of 8.89 6 0.93 Hz
(mean 6 SE) at 8.5 log10 quanta s1deg2. The plateau
frequency was considerably lower in patients compared to
normal observers (means of 29.88 and 40.18 Hz, respectively).
Figure 2 shows the logarithm of L-cone temporal modula-
tion sensitivity as a function of temporal frequency measured
with 48 targets at a time-averaged 650-nm target radiance of
10.6 log10 quanta s
1deg2 for all observers. The mean data for
8 normal observers are shown in each image as gray triangles,
while those for each of the 11 DOA patients are shown in the
first 11 images as colored triangles. The mean data for the DOA
patients are shown in the bottom right-hand image as filled
triangles. The sensitivity differences between the DOA and
mean normal data are shown in each image by the circles. The
fits of the cubic polynomial model (described in Methods) are
shown as black curves. The fitting parameters are given in
Table 4.
The mean L-cone modulation sensitivity function for normal
observers peaks in sensitivity at 6.48 6 0.30 Hz and falls off in
sensitivity at both low and high temporal frequencies.31–33 This
shape of sensitivity function is known as a band-pass function;
the decline in sensitivity at low temporal frequencies is often
attributed to surround antagonism.41,42 The temporal contrast
FIGURE 2. L-cone modulation sensitivity. Each image shows, for a single DOA patient, the log10 L-cone modulation sensitivities measured using a
sinusoidally modulated, 650-nm 48 target with a mean radiance of 10.3 log10 quanta s1deg2 superimposed on a 98, 481-nm background of 8.3 log10
quanta s1deg2 and plotted as a function temporal frequency colored triangles. (The gray symbols in each image show the mean normal data set for
comparison.) The 12th (gray) image shows the mean DOA data (black triangles). The error bars are 61 SEM either between runs for the individual
patients, or between observers for the mean data. In the lower part of the first 11 images, the differences in log10 sensitivity between each DOA
patient and the normal mean data (n¼ 8) are shown as circles. The 12th image shows the differences between the mean data (filled circles). The
black curves are the fits of the cubic polynomial model described in Methods.
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sensitivity functions for all but one of the DOA patients (P1)
were also band-pass in shape with a lower peak to the normal
function (mean 6 SEM: 5.53 6 0.59 Hz), but they showed a
mean peak sensitivity loss of 0.66 log10 units (mean 6 SEM)
(see image 12). The mean loss, shown in image 12, is roughly
independent of temporal frequency. However, there are
individual differences. The band-pass peaks for P9 and P10
are shifted to lower temporal frequencies and therefore
showed bigger losses at high temporal frequencies. And the
cone temporal contrast sensitivities (TCSFs) for P1 and P3 were
fairly flat, so that the sensitivity relative to normal observers
increased at higher temporal frequencies.
In conclusion, L-cone TCSFs were characterized by reduced
temporal acuity or CFF, a mild but significant reduction in the
Ferry-Porter CFF slope, and a general loss of sensitivity. L-cone
temporal acuity showed weak age-related effects in terms of an
increase in Ferry-Porter slope and a decrease in the plateau
frequency, but CFF was approximately constant at middle
intensities (see Fig. 1C).
S-Cone Temporal Function—Critical Flicker Fusion
Figures 3A and 3B show S-cone CFF data plotted as a function
target radiance, and Table 5 tabulates CFF characteristics: the
lowest detected target radiance, the Ferry-Porter slope, and the
CFF frequency at 8.5 log10 quanta s
1deg2 target radiance, for
DOA and normal observers as in Table 3 but for S-cones. The
data for 15 normal observers are again shown with gray
symbols as mean 6 1 SEM. In the normal observers, S-cone CFF
starts to rise above a radiance of 6.5 log10 quanta s
1deg2 until
reaching a plateau of approximately 22 Hz at 9.0 log10 quanta
s1deg2. The linear relation between CFF and radiance,
consistent with the Ferry-Porter law, is 7.3 Hz per log10 quanta
s1deg2 for normal observers at radiances below the plateau.
(The rise after 9.9 log10 quanta s
1deg2 is due to M-cones
becoming more sensitive than S-cones at high target radianc-
es.33,43)
The data for each DOA patient are presented with
individually colored symbols in Figure 3A. The data for S-cone
CFF was severely abnormal for the oldest DOA patients (P9 and
P10, 52 and 54 years old, respectively), so that P9 could not
detect any flicker with a 440-nm target and P10 detected
flicker only at the highest radiance (a radiance for which, in
normal observers, M-cones are more sensitive than S-cones).
The youngest DOA patients, in contrast, had normal Ferry-
Porter slopes and near normal CFF frequencies at 8.5 log10
quanta s1deg2 as shown in Figure 3C where the S-cone CFF
frequencies at 8.5 log10 quanta s
1deg2 are plotted as a
TABLE 4. Peak and Maximal Sensitivity and Highest Visible TCSF
Frequency
Observer
TCSF
Maximum Visible
Temporal
Frequency, Hz
Peak
Temporal
Frequency, Hz
Peak log10
Sensitivity
P1 151.2 3.75 0.68
P2 49.8 5.60 1.81
P3 76.1 7.87 1.28
P4 36.0 6.00 1.23
P5 45.6 7.66 1.55
P6 37.3 4.82 1.52
P7 28.7 4.55 1.33
P8 35.7 7.34 1.37
P9 28.3 3.16 1.31
P10 32.5 2.44 1.80
P11 45.6 7.66 1.55
DOA mean 6 SE 51.5 6 10.8 5.53 6 0.59 1.40 6 0.09
Normal mean 6 SE 50.8 6 0.9 6.48 6 0.30 2.06 6 0.06
FIGURE 3. S-cone critical flicker fusion. (A, B) S-cone critical flicker
frequencies (CFF) measured on a 98 620-nm background of 11.41 log10
quanta s1deg2 plotted as a function of the mean log10 radiance of a
440-nm flickering target. (A) Data are plotted as mean 6 1 SEM for
each DOA patient indicated with individually colored symbols and as
gray symbols for the mean normal observer. (B) Mean DOA data with
61 SEM across DOA patients indicated with cyan symbols. The gray
symbols denote to the mean normal data again with 61 SEM across 15
observers. The Ferry-Porter slopes of mean CFF for DOA and normal
observers are indicated with blue lines. (C) The S-cone CFF frequencies
at 8.5 log10 quanta s
1deg2 plotted as a function of observer age, and
the best fits for linear regression (solid lines) and 95% confidence
intervals (dashed lines), for DOA patients (cyan symbols and lines) and
for normal observers (gray symbols and lines).
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function of observer age for normal (gray symbols) and DOA
(cyan symbols) observers. S-cone CFF at 8.5 log10 quanta
s1deg2 showed a significant age-related variation for the DOA
patients (Pearson’s r ¼ 0.920, P < 0.001) but not for the
normal observers (Pearson’s r¼0.326, P¼0.236). Also S-cone
plateau frequency at 9.2 to 9.4 log10 quanta s
1deg2 target
radiance and the lowest detected radiance showed significant
age correlation (Pearson’s r¼0.838, P¼0.005 for plateau and
Pearson’s r ¼ 0.667, P ¼ 0.050 for lowest radiance). (Severely
impaired S-cone temporal acuity associated with lowered S-
and M-cone–related chromatic sensitivities as will be presented
in detail later on). The mean CFF data for the DOA patients are
shown in Figure 3B (cyan triangles).
Achromatic Spatial Contrast Sensitivity Function
Figure 4 and Figure 5A show achromatic SCSFs, that is,
sensitivity plotted in log10 units as a function of spatial
frequency (cyc/deg) plotted on a logarithmic scale. The mean
data for 15 normal observers are shown with gray symbols and
have a peak mean contrast sensitivity of 2.19 6 0.03 log10
(mean 6 SEM) at a mean spatial frequency of 2.18 6 0.15 cyc/
deg (mean 6 SEM). Like the TCSF, the SCSF also has a band-
pass shape with losses at lower spatial frequencies probably
resulting from surround inhibition.41,44,45 The response at the
highest spatial frequencies is limited jointly by the modulation
transfer function of the optics and the size of the receptive
field center, so that only neurons with the smallest receptive
fields are able to respond to the highest frequencies.46–48
The data for DOA P1 to P25 are shown with individually
colored symbols as mean 6 1 SEM in the upper part of each
image (colored triangles), together with normal data (inverted
gray triangles). Differences in sensitivity between individual
DOA patients and normal are shown as colored circles in the
lower part of each image. There is little loss in sensitivity at low
frequencies for the DOA patients, with the exception of P8, P9,
P18, P19, and P24, but all DOA patients show substantial losses
relative to normal observers at high spatial frequencies.
The fits of the cubic polynomial functions are shown as
black curves in Figures 4 and 5. The maximum visible
frequency is taken as the zero crossing of the cubic function,
and the maximum sensitivity and peak frequency can be found
as the local maximum in the cubic function, if it exists. Table 6
tabulates these values. Note that for nine patients (denoted by
asterisk) the TSCF appears low-pass with no discernible peak
in sensitivity, and in these cases, for analysis purposes, the peak
frequency was defined as the lowest frequency tested (0.5 cyc/
deg) and the peak sensitivity was simply the sensitivity at that
frequency.
Figure 5A presents the mean achromatic SCSF for the entire
25 DOA patient group. The patients have a significantly lower
achromatic spatial contrast sensitivity than normal with a mean
peak sensitivity of 1.42 6 0.07 log10 (mean 6 SEM) shifted to
the spatial frequency of 0.72 6 0.06 cyc/deg (mean 6 SEM).
The sensitivity loss increased nearly linearly toward high spatial
frequencies, and mean CSF function was low-pass or band-pass
for the DOA patients instead of being consistently band-pass in
the normal observers. The difference in peak sensitivity for
patients compared to normal observers was not correlated
with the sensitivity losses found in the TCSF data (Pearson’s r¼
0.284, P ¼ 0.426).
The spatial acuity at maximum contrast derived from the
model fits for each is plotted in Figure 5B. The highest
observed spatial frequency under maximal contrast (corre-
sponding to zero sensitivity) relates to spatial visual acuity
expressed as logarithm of the minimum angle of resolution
(logMAR), so that 0 logMAR corresponds to 30 cyc/deg.49 This
value for spatial frequency corresponds to the extrapolated
intercept of the contrast sensitivity function at zero sensitivity.
Figure 5A shows the mean achromatic SCSF for DOA and
normal observers and extrapolation of SCSF to zero sensitivity
at the intersection with the horizontal gray dashed line. Figure
5B shows the spatial frequencies obtained by extrapolation of
SCSF of each observer at zero sensitivity plotted as a function
of BCVA expressed in logMAR units. In normal observers with
normal visual acuities (0 logMAR), the extrapolated SCSF at
zero sensitivity had median intercept at 23.8 6 1.09 cyc/deg
(median 6 SEM). In the DOA patients with BCVA better than
1.0 logMAR, the SCSF intercepts correspond roughly with the
BCVA values. The logMAR is a reasonable predictor of spatial
acuity below 0.75, but not above it. There was no sex-related
variation in the BCVA (Mann-Whitney U test, P ¼ 0.210).
The achromatic SCSF has a spatial frequency–dependent
contribution from several RGC subpopulations: (1) Midget
cells with the smallest receptive field probably mediate the
highest spatial frequencies44,48; (2) OFF midget cells may have
TABLE 5. S-Cone Critical Flicker Fusion Variables
Observer
S-Cone
Lowest Radiance,
log10 quanta s1deg2
Ferry-Porter Slope,
Hz per Decade R2
Frequency, Hz, at 8.5 log10
quanta s1deg2 Radiance
Plateau Frequency,
Hz, at 9.2–9.4 log10
quanta s1deg2
P1 7.12 7.09 0.95 18.86 21.75
P2 7.11 6.78 0.98 17.76 21.17
P3 8.95 6.71 0.94 9.21 13.75
P4 7.65 6.60 0.97 13.75 18.67
P5 8.57 4.87 0.99 7.45 11.06
P6 8.08 4.91 0.98 6.00 11.42
P7 8.30 5.21 0.92 7.73 10.55
P8 8.95 3.46 0.99 7.95 13.75
P9 U U U 0 U
P10 10.04 U U 0 U
P11 7.38 5.84 0.96 13.42 15.56
DOA mean 6 SE 8.22 6 0.94 5.72 6 0.36 0.96 6 0.01 9.28 6 1.89 15.30 6 1.32
Normal mean 6 SE 6.77 6 0.09 7.28 6 0.29 0.998 18.99 6 0.89 23.88 6 0.98
Mann-Whitney U test, P <0.001 0.012 <0.001 <0.001
U, unmeasurable.
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more significant contribution at low spatial frequencies than
ON midget cells45; (3) parasol RGCs are also sensitive to low
spatial frequencies.50 We analyzed the statistical dependence
between the nonspatial variables (age, the structural findings,
visual field defect, temporal data, chromatic data) and the
spatial losses at low (0.75 cyc/deg) and higher (4 cyc/deg)
spatial frequencies separately. Losses at both frequencies,
however, showed similar associations with the field and color
vision defects and the structural variables, and no correlation
with the temporal data (studied within the 11-patient
subgroup) or dependence on age.
Chromatic Discrimination
Figure 6 shows the vector lengths of the three confusion lines
(protan, deutan, and tritan) of the CCT in 104 u0v 0 units (the
CIE 1976 u0v 0 color space) for 21 DOA and 15 normal
observers presented as a function of observer’s age. The
longer the vector length, the more saturated color was
required for color discrimination, with the maximum
saturation corresponding to the vector length of 1600 104
u0v 0 units (the CIE 1976 u 0v 0 color space). In the normal
observers (smaller partially transparent symbols), the vector
lengths were similar to those previously reported using the
FIGURE 4. Achromatic spatial contrast sensitivity functions (SCSFs), expressed as log10 sensitivity as a function of spatial frequency (cycles per
degree, cyc/deg—logarithmic axis), are indicated with colored triangles for (A) the 11 individual DOA patients who also participated in the
temporal measurements and (B) the 14 individual DOA patients who did not, in separate images together with normal data (inverted gray
triangles). The difference in sensitivity between each DOA patient and normal is also indicated in each image by colored circles. The symbols and
error bars are mean 6 1 SEM across normal observers, or across repeated runs of individual DOA patients. The black curves are fits of a cubic
polynomial model, as described in the text.
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standard long viewing distance with the gap in the letter C
opening subtending 18 of visual angle: 45.1 6 1.0 for protan,
43.3 6 0.8 for deutan, and 51.5 6 1.3 for tritan in 104 u 0v 0
units (the CIE 1976 u 0v0 color space) (mean 6 SEM).51 No
significant age-related variation in any of the confusion lines
was observed in normal observers.
Dominant optic atrophy patients had abnormal chromatic
contrast sensitivity on all three confusion lines with the
following mean vector lengths: 659 6 94 for protan, 696 6 94
for deutan, and 988 6 111 for tritan in 104 u0v0 units (the CIE
1976 u0v0 color space) (mean 6 SEM). Three DOA patients
could not detect even the most saturated color in any of the
confusion lines, and their data are not included in Figure 6.
Two of them, aged 34 and 65 years, carried OPA1 c.733A>T
mutation, and the third patient, aged 39 years old, OPA1
c.112C>A mutation. In addition, OPA1 c. 1296delCAT
mutation associated with early loss of red–green color vision,
unrelated to the visual acuity or field losses, and with an equal
loss of color discrimination in all three confusion lines,
whereas in the other genotypes the tritan axis was always
more severely affected. There was thus evident genotype-
related variation in the chromatic discrimination. However, in
general, color vision deteriorated with increasing patient age
(Pearson’s r¼ 0.545, P¼ 0.011 for protan, r¼ 0.581, P¼ 0.006
for deutan, and r¼0.710, P < 0.001 for tritan axes). There was
no sex-related variation in the chromatic discrimination (Mann-
Whitney U test, P¼ 0.891 for protan, P¼0.891 for deutan, and
P ¼ 0.945 for tritan axes).
For comparison of regression rates between color vision
along the tritan confusion line and S-cone temporal acuity, data
for the 11 DOA patients undergoing both tests were converted
to percentage of the normal values and referred to the observer
FIGURE 4. Continued.
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age. Both short wavelength–related visual functions showed
similar regression (Pearson r ¼ 0.734, P ¼ 0.010 for tritan
vector length, and r ¼0.856, P ¼ 0.001 for S-cone temporal
acuity) corresponding to annual deterioration of 1.9% for both
functions.
OCT Structural Data
The mean macular GCL-IPL thickness in 50 eyes of 25 DOA
patients was 39.7 6 1.10 lm (mean 6 SEM), that is, 42% of the
normal, 93.5 6 1.4 lm (mean 6 SEM). The mean peripapillary
RNFL thickness was 61.9 6 1.2 lm (mean 6 SEM),
corresponding to 63% of the normal and to that previously
reported in another cohort of nonsyndromic DOA.52 Figure 7
shows the thickness of the GCL-IPL complex measured from
the macular SD-OCT images of 50 eyes of 25 DOA patients
(pink triangles) and of 48 normal eyes (gray inverted triangles)
plotted as a function of age. Dominant optic atrophy patients
had significantly thinner GCL-IPL complex than normal at all
ages, but the best fit for linear regression of the GCL-IPL
thickness both for normal subjects (Pearson’s r¼0.470, P <
0.001) and for DOA patients (r ¼ 0.685, P < 0.001)
corresponded to 0.2 lm loss and 0.2% per year. Dominant
optic atrophy patients did not show any sex-related variation in
the GCL-IPL thickness (Mann-Whitney U test, P ¼ 0.240).
DISCUSSION
Visual impairment in DOA was characterized by losses that can
be associated with all three visual pathways, but with
inhomogeneous severity and age-related variation. The loss of
midget RGCs could account for the loss of high spatial
frequency sensitivity that was markedly subnormal in most
DOA patients at all ages. It could also account for the loss of
chromatic resolution along the protan and deutan color
confusion lines, which showed clear deterioration with
increasing patient age. By contrast, the loss of parasol RGCs,
which could account for the loss of high temporal frequency
acuity, was mild and without significant age-related variation.
The most striking age-related visual losses, however, were
observed for the S-cone–mediated chromatic and temporal
sensitivities, which could result from the loss of small
bistratified RGCs.
Visual perception results from the sequential and parallel
transmission and processing of signals from the photorecep-
tors through the visual system. In DOA, there is no evidence of
functional or structural abnormalities in the outer retina7,53–55;
and although a subgroup of patients carrying pathogenic OPA1
mutations can develop a more severe neurologic phenotype
and nonspecific white matter cortical abnormalities, the
neuropathology in the majority of patients is limited to the
optic nerve.56 The psychophysical abnormalities identified in
our patient cohort could therefore be attributed to RGC loss or
dysfunction. At this level of the visual pathway, perception
depends on the parallel transmission of signals by different
subpopulations of RGC types that encode different character-
istics of visual target.44,57 In DOA patients, the parasol RGC–
related visual functions showed a lowered temporal acuity, a
slower increase in acuity with increasing radiance than normal,
and a roughly constant sensitivity loss across temporal
frequencies. Could these findings be attributed to loss of a
particular population of RGCs (e.g., the parasol cells) or to
functional abnormalities within surviving members of that
population? Psychophysical studies following a magnocellular
lateral geniculate lesion in macaques revealed TCSF losses that
increase with temporal frequency, but with some preservation
of low frequency sensitivity, thus changing the shape of the
TCSF from band-pass to low-pass.58,59 The pattern of magno-
cellular visual function in DOA differs from that reported for
the anatomic loss of the magnocellular pathway. In contrast,
nearly identical temporal losses to that observed in DOA have
been described for single parasol RGC firing pattern in
experimental primate glaucoma.60 In this model there was
loss of the temporal acuity by 10 Hz, attenuation of the
temporal sensitivity in the most dysfunctional RGCs also at low
frequencies, and preservation of the band-pass sensitivity
function. The extent of the functional abnormalities correlated
FIGURE 5. (A) Mean achromatic spatial contrast sensitivity function (CSF) of 25 DOA (pink triangles) and 15 normal observers (gray triangles)
expressed in log10 sensitivity as a function of spatial frequency (cycles per degree, cyc/deg—logarithmic axis). (Extrapolation of the fitted SCSFs to
zero sensitivity; that is, sensitivity corresponding to the maximum [100%] sinusoidal contrast, is determined by the spatial frequency at which the
SCSFs intersect the horizontal gray dashed line.) The mean sensitivity difference between DOA patients and the mean normal observer is shown as
colored circles in the lower image. The symbols and error bars are mean 6 1 SEM within both groups. The black curves are the model fits, as
described in the text. (B) Spatial frequency (cyc/deg) at zero sensitivity (logarithmic axis) is plotted as a function of the best-corrected visual acuities
(BCVA) of both eyes. The gray line denotes the correlation between the spatial frequency and the visual acuity expressed in logMAR units. The data
for DOA patients are presented as a scatter plot, and data for normal observers as a box plot showing median, range (error bars), interquartile range
(box), and an outlier (black dots).
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with the loss of normal RGC dendritic arborization that is
thought to represent the first sign of RGC degeneration in
glaucoma.61 A similar structural feature has also been found in
the B6;C3-Opa1Q285STOP mouse model as a precursor of RGC
degeneration.62 The architecture of dendritic arborization in
patients with OPA1 mutations is not known, but our data
support the idea that loss of dendritic arborization may be
involved in the pathogenesis of DOA rather than just
population loss.
Previous psychophysical studies in nonhuman primates on
the effect of the parvocellular lateral geniculate lesion have
shown losses of the high and low spatial frequency contrast
sensitivity and a change from a band-pass to a low-pass SCSF
consistent with detection by the magnocellular pathway.63
Achromatic spatial contrast sensitivity in our DOA patient
cohort had similar characteristics. However, experimental
models of parvocellular pathway lesion also resulted in
complete loss of color vision,58 which was observed in only
a few DOA patients carrying a particular genotype (genotype
10, c.733A>T), or with the most advanced disease (genotype
11, c.112C>A). This suggests that the parvocellular lesion in
DOA preserves sufficient midget RGCs to support chromatic
resolution along the protan and deutan axes,64 but because of
progressive loss there is also a steep age-related regression.
Our results are in line with the report by Reis and
colleagues28 that showed increasing contrast thresholds at
higher spatial frequencies for their DOA patients, although
less than half of their cohort carried confirmed pathogenic
OPA1 mutations. Our study also supports the structural and
functional evidence pointing toward the midget cells as being
the mainly affected RGC type in DOA, such as the
predominance of the midget cells in the macular RGC
population subserving central vision, and the preferential
loss of the small-diameter axons in postmortem histopatho-
logic studies65,66 and in a recent OPA1 mouse model.67 Toxic
and inflammatory insults to midget RGCs do not result in loss
FIGURE 7. Macular ganglion cell–inner plexiform layer (GCL-IPL)
thickness (lm) for 50 eyes of 25 DOA patients (pink symbols) and
for 48 healthy eyes (gray symbols) plotted as a function of subject age
and including lines for the best fits of linear regression and 95%
confidence intervals.
TABLE 6. Peak and Maximal Sensitivity and Highest Visible SCSF
Frequency
Observer
SCSF
Maximum Visible
Spatial Frequency,
cyc/deg
Peak Spatial
Frequency,
cyc/deg
Peak log10
Sensitivity
P1 6.31 0.68 1.40
P2 15.59 0.84 1.64
P3 6.63 0.50* 1.63*
P4 4.44 0.71 1.46
P5 9.35 0.84 1.69
P6 6.26 0.50* 1.25*
P7 10.04 0.92 1.68
P8 9.62 1.16 1.63
P9 8.36 1.31 1.66
P10 9.60 0.50* 1.37*
P11 6.08 0.70 1.55
P12 12.85 1.07 1.99
P13 6.83 0.50* 1.47*
P14 4.94 0.50* 1.95*
P15 3.38 0.50* 1.27*
P16 7.31 0.74 1.50
P17 6.03 0.58 1.29
P18 4.80 0.62 1.38
P19 1.60 0.53 0.61
P20 4.20 0.59 0.93
P21 18.27 1.60 2.01
P22 9.34 0.50* 1.43*
P23 6.23 0.51 1.75
P24 –† 0.50* 0.80*
P25 2.50 0.50* 1.43*
DOA mean 6 SE 7.52 6 0.80 0.72 6 0.06 1.42 6 0.07
Normal mean 6 SE 23.81 6 1.09 2.18 6 0.15 2.19 6 0.03
* SCSF is not band-pass so ‘‘peak frequency’’ set to lowest measured
and ‘‘peak sensitivity’’ set to the measured sensitivity at this frequency.
† Fitted function does not have a plausible value of the zero
crossing, so maximum visible spatial frequency is undefined.
FIGURE 6. The Trivector Cambridge Colour Test. The vector lengths in
the protan and deutan (A) and tritan (B) confusion lines expressed in
104 u0v0 units (the CIE 1976 u0v0 color space) as a function of observer
age for 23 DOA (colored symbols: upper image, red triangles for
protan, inverted green triangles for deutan, and lower image, blue
triangles for tritan). Normal observers in both images (small gray
diamonds). Solid lines are for the best linear regression and dashed
lines for the 95% confidence intervals.
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of mainly the high spatial frequencies,68–70 which implies that
the preferential loss of the small receptive field midget cells
may be specific to DOA.
The most extensive visual impairment was loss of S-cone
chromatic and temporal sensitivities in the oldest DOA
patients. This observation could be related to dysfunction of
the small bistratified RGCs, which support S-cone vision (see
above). Unlike normal age-matched observers, this group of
DOA patients had unmeasurable chromatic resolution along
the tritan confusion line and they were unable to detect
flickering short-wavelength light. Loss of perception of the
blue colors in DOA was also among the early observations by
Kjer7 and the most frequently reported color vision defect in
this disorder.1,4,25–29 Reports showing clear age-related varia-
tions are, however, scarce; and this could be explained by the
differences in the testing conditions used. The Trivector test
procedure of the CCT enables better discrimination and
quantitative assessment of the individual color axes than the
elliptical test procedure previously used in another study.27
Furthermore, our modifications of the viewing distance and
response time, in turn, enabled use of the test for patients with
varying impairment of the spatial resolution. Temporal
sensitivity test of the koniocellular pathway (i.e., S-cone CFF)
introduced an independent method for the assessment of the
small bistratified RGC function. Importantly, this modality
showed loss with increasing patient age identical to that
observed for chromatic sensitivity.
A cross-sectional study does not allow disease progression
to be followed at the individual level, but a prospective long-
term longitudinal study in DOA is challenging. Despite these
caveats, we carefully designed our study to include DOA
patients covering a broad range of disease duration, and this
approach enables us to speculate on a particular pattern and
chronology of RGC loss in this disorder. Firstly, the macular
GCL-IPL thickness in DOA patients was less than 50% of
normative values and with a similar rate of decline with
increasing age compared with healthy controls. Similar findings
have been reported in other DOA cohorts,9–11 and taken
together, the evidence indicates that a major proportion of the
RGC loss has already occurred in early childhood, and probably
starting in utero. If the remaining 50% of the GCL-IPL thickness
is liberally converted to RGC density, that is, 50% of the
foveolar maximum, this corresponds approximately to the
RGC density found at a foveolar eccentricity of 78 in normal
retina.48 Such an RGC density enables spatial resolution of 9
cyc/deg,48 which could be used as an estimate for the
theoretical upper limit of spatial visual acuity in DOA.
Interestingly, in the majority of our DOA patients, the spatial
acuities were of that level, or below, leading to an interpreta-
tion that the high-density small receptive field midget RGCs
could constitute the majority of the 50% RGC population that
has already been lost.
Parasol and small bistratified cells form only a small
proportion of the total RGC population, and detecting their
loss may not be possible with current in vivo imaging
techniques, requiring instead more sensitive functional psy-
chophysical testing methods. Our results indicate that parasol
RGCs are functionally compromised in DOA, but there is no
clear evidence of continuing cell loss. In contrast, the
functioning of the koniocellular S-cone pathway seems to
rapidly deteriorate with increasing patient age, an observation
that is consistent with the ongoing loss of small bistratified
RGCs. The majority of patients with DOA will experience
gradual loss of visual function, and although this provides an
extended window of opportunity for therapeutic intervention,
designing cost-effective clinical trials to detect a favorable
outcome measure within a reasonable time frame is challeng-
ing. Although a prospective longitudinal study is needed to
confirm our findings for individual OPA1 mutation carriers,
monitoring koniocellular pathway function with S-cone–
mediated chromatic and temporal sensitivities could potential-
ly provide useful biomarkers of disease progression in DOA.
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